W., Jiang, X
( Epub 2025 Apr 30 PMID: 40318682 ) Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, SURMOUNT-1 Investigators (2022) Tirzepatide once weekly for the treatment of obesity
This makes it a compelling option for individuals who have had limited success with conventional treatments or who are seeking alternatives with a more favorable side effect profile
When prescribing GLP-1 medications for individuals with advanced kidney disease, extra care is essential to ensure both safety and effectiveness
Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis. Ellulu, Mohammed S., et al
More severe side effects are rare but discussed in detail during consultations to ensure patient safety